|
Aleksandra Pettke
|
Stockholm, Sweden
|
Development of serological methods for MPXV to advance the sero-epidemiology field and close diagnostic gaps between high- and low-income countries
|
|
Anna Boté Casamitjana
|
London, United Kingdom
|
Prevalence of Asymptomatic Malaria in Pregnant Women from Africa
|
|
Antonia Walther
|
Munich, Germany
|
Prevalence and Health Impact of Schistosomiasis in CYPSAR (Children and Young People Seeking Asylum and Refugees) in Germany - A prospective Cohort study
|
|
Axel Dietschmann
|
Jena, Germany
|
Trained resilience to fungal infections: Unravelling how macrophages teach each other to fight off Candida albicans
|
|
Brice Autier
|
Rennes, France
|
MacSeq-AE: Deciphering heterogeneity of macrophages involved in alveolar echinococcosis by single-cell RNA sequencing
|
|
Camilla Albano
|
Turin, Italy
|
Lipid Metabolism in HSV-1 Infection: Insights into Viral Replication and Potential Therapeutic Targets
|
|
Camille Kolenda
|
Lyon, France
|
Development of the next generation of phage therapy: understanding bacterial determinants of phage activity and overcoming resistance
|
|
Cunha Baptista Vitória
|
Braga, Portugal
|
LIHEME: Unraveling lipid-dependent mechanisms in heme detoxification
|
|
Daniel Pan
|
Leicester, United Kingdom
|
Exhaled immune markers in COVID-19 and household transmission: towards defining individual infectivity in respiratory virus infection
|
|
Filippo Favretto
|
Verona, Italy
|
Repurposing non-immunosuppressive cyclosporin A analogs for targeting Strongyloides stercoralis cyclophilins
|
|
Francelise Bridi Cavassin
|
Curitiba, Brazil
|
An open-label, randomized, non-inferiority trial comparing itraconazole and terbinafine for the treatment of Cat-Transmitted Sporotrichosis (CTS) in pediatrics: a pilot study in Curitiba, Brazil
|
|
Francisco Olmo Arévalo
|
Granada, Spain
|
Unravelling protozoan parasite Trypanosoma cruzi infection in the nervous system
|
|
Gloria Griffante
|
Torino, Italy
|
ZNF638 controlling Epstein-Barr virus latency as determinant of multiple sclerosis pathogenesis
|
|
Huma Khan
|
Swabi, Pakistan
|
Implementation of a pilot Capacity building progrAm in Pakistan, a Cystic EchInococcosis endemic country based on ulTrasound pOpulation surveys for prevalence and Risk factor assessment – the CAPACITOR-A study
|
|
Ikechukwu Benjamin Moses
|
Abakaliki, Ebonyi State, Nigeria
|
LIHEME: Unraveling lipid-dependent mechanisms in heme detoxification
|
|
Jacopo Angelini
|
Udine, Italy
|
Real-life data to Better characterIze exposure to Acyclovir in pregNant women with Cytomegalovirus infection: A clinical need for the present and an opportunity for the future. The BIANCA study.
|
|
Jana Van Dycke
|
Leuven, Belgium
|
Investigating Hepatitis E Virus Infection in a Gut on Chip Model
|
|
Joao Canto-Gomes
|
Braga, Portugal
|
REVERT-MS - Studying the Repertoire of Epstein-Barr Virus-specific HLA-E-Restricted CD8+ T-cells in Multiple Sclerosis
|
|
Lander De Herdt
|
Leuven, Belgium
|
Eosinophil-induced airway remodelling as novel gateway and therapeutic target for Cryptococcus neoformans dissemination
|
|
Laura Seldeslachts
|
Leuven, Belgium
|
Inflammasomes in influenza-associated pulmonary aspergillosis: from mechanisms to host-directed therapy
|
|
Marius Ahm Stauning
|
Copenhagen, Denmark
|
Changes in molecular markers related to malaria vaccine susceptibility in Plasmodium falciparum and changes in Plasmodium species composition after introduction of malaria vaccines in the Democratic Republic of Congo
|
|
Matteo Augello
|
Milan, Italy
|
Association between ultra-low level soluble p24 and adverse clinical outcomes in virologically supressed people with HIV (SpARROW)
|
|
Mélanie Burette
|
Montpellier, France
|
Deciphering the mechanisms behind rhoptry secretion in the Apicomplexa parasite Toxoplasma gondii
|
|
Mitchell Pallett
|
London, United Kingdom
|
Stopping Cryptosporidium in its tracks: A high-throughput screen for identifying neutralising nanobodies
|
|
Paola Saltini
|
Milano, Italy
|
Safety and immunogenicity of RSV vaccine RSVPreF3 OA among immunocompromised hosts: a single centre cohort study (FURIOUS study)
|
|
Patil Rutuja Hiraji
|
Prague, Czech Republic
|
Aspergillus-Pseudomonas Interaction Modulated by Human Neutrophils
|
|
Philippa Mcdermid
|
Nsw, Australia
|
Enhancing patient and visitor hand hygiene to reduce the risk of healthcare-associated infections
|
|
Rhea O'Regan
|
Dublin, Ireland
|
Investigating the diagnostic utility of PhIP-Seq in the management of Acute Undifferentiated Febrile Illnesses
|
|
Salvatore Scarso
|
Negrar Di Valpolicella, Italy
|
Optimizing the diagnosis of Female Genital Schistosomiasis through self-sampling and molecular detection: the OPTI-ShWAB study
|
|
Samuel Martins Gonçalves
|
Braga, Portugal
|
Dissecting cholesterol-mediated mechanisms of antifungal immunity in invasive pulmonary aspergillosis
|
|
Siegel Eric
|
Massachusetts, United States
|
Targeting Borrelia burgdorferi's Inosine Monophosphate Dehydrogenase (IMPDH/GuaB) for Lyme Disease Control: Foundational Studies on Therapeutic Testing Infrastructure and Risk Assessment Applications
|
|
Simon Feys
|
Leuven, Belgium
|
LAVA (Lymphocytic Assessments in Viral-associated pulmonary Aspergillosis)
|
|
Sissy Lamprecht-Sonnleitner
|
Graz, Austria
|
Exploration of the Diversity and Diagnostic Potential of Burkholderia pseudomallei-specific Phages from Environmental and Clinical Sources: A Nanopore Sequencing and Prophage Induction Approach
|
|
Tatjana Schwarz
|
Berlin, Germany
|
Uncovering HEV Immune Responses Through Enhanced Serological Diagnostics and Epitope Mapping
|
|
Thomas Roodsant
|
Bilthoven, Netherlands
|
Wastewater Surveillance of Cryptosporidium
|
|
Wouter Smit
|
Ankeveen, Netherlands
|
Assessment of perioperative Torque Teno Virus load dynamics as a prognostic biomarker in plasma of ICU patients following elective high-risk surgical procedures
|
|
Wouter Van Genechten
|
Leuven, Belgium
|
Unraveling the role of Candida albicans and its G-protein coupled receptor, Gpr1, in the gastrointestinal tract microbiome.
|
|
Yuan Seng Wu
|
Bandar Sunway, Malaysia
|
Development of antiviral molecules based on embelin scaffold against Dengue
|
